BD Announces Change to Virtual 2022 Annual Meeting of Shareholders

FRANKLIN LAKES, N.J., Jan. 6, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that in the interest of the health and safety of its shareholders, directors, officers, employees and meeting attendees in light of the current and ongoing COVID-19 pandemic, the format of its 2022 Annual Meeting of Shareholders (the "2022 Annual Meeting") has been changed to a virtual-only meeting. BD's 2022 Annual Meeting will be held on Tuesday, January 25, 2022 at 1:00 p.m. EST, as previously announced.

Shareholders will not be able to attend the 2022 Annual Meeting in person; however, shareholders of record at the close of business on December 6, 2021 will be able to attend and participate in the virtual 2022 Annual Meeting, vote their shares and ask questions by visiting as described below. Guests may also access the virtual 2022 Annual Meeting but in listen-only mode. No control number is required for guests.

Registered Holders: If you are a registered shareholder (i.e., you hold your shares through BD's transfer agent, Computershare), you will be able to attend and participate in the virtual 2022 Annual Meeting, vote your shares and ask questions by visiting and entering the 15-digit control number found on your proxy card or notice that accompanied your proxy materials.

Street Holders: If your shares are held in "street name" (i.e., you hold your shares through an intermediary, such as a bank or broker), you must register via either of the following two options:

Registration in Advance of the Virtual 2022 Annual Meeting: To register in advance, you must submit proof of your proxy power ("Legal Proxy") from your bank or broker reflecting your ownership of Becton, Dickinson and Company common stock. Please forward a copy of the Legal Proxy along with your name and email address to Computershare. Requests for registration should be directed to Computershare either by email to (forwarding the email from your broker, or attach an image of your legal proxy) or by mail to Computershare, Becton, Dickinson and Company Legal Proxy, P.O. Box 43001, Providence, RI 02940-3001.

Requests for registration must be labeled as "Legal Proxy" and be received no later than 5:00 p.m., EST, on January 20, 2022. You will receive a confirmation of your registration by email (or by mail, if no email address is provided) after Computershare receives your registration materials. If you have already voted your shares and then request a Legal Proxy, your original vote will be invalidated and you will be required to vote your shares again for your vote to be counted.

Registration at the Virtual 2022 Annual Meeting: Street holders may register online at the virtual 2022 Annual Meeting by using the control number found on their voting instruction form. We expect the vast majority of street holders to be able to fully participate using the control number received from their broker or nominee with their voting instruction form. To confirm whether the control number you received from your broker or nominee will allow access to the Virtual 2022 Annual Meeting, please contact them. If it will not, you will need to follow the more detailed registration process described above under "Registration in Advance of the Virtual 2022 Annual Meeting." The inability to provide this option to any or all street holders shall in no way impact the validity of the 2022 Annual Meeting.

The virtual 2022 Annual meeting will begin promptly at 1:00 p.m. EST. We encourage you to access the meeting at least 15 minutes prior to the start time to provide ample time for logging in. Rules of conduct for the virtual 2022 Annual Meeting will be posted on the 2022 Annual Meeting website at

Whether or not you plan to virtually attend BD's 2022 Annual Meeting, BD urges shareholders to vote and submit their proxy in advance by one of the methods described in the proxy materials for the 2022 Annual Meeting. The notice of meeting, proxy card and voting instruction form included with the previously distributed 2022 Annual Meeting proxy materials will not be updated and may continue to be used for voting purposes at BD's 2022 Annual Meeting.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit or connect with us on LinkedIn at and Twitter @BDandCo.


Troy Kirkpatrick

Francesca DeMartino

VP, Public Relations

SVP, Investor Relations




Cision View original content to download multimedia:

SOURCE BD (Becton, Dickinson and Company)